Opko Health, Inc.
OPK
$1.31
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 31.71% | -16.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 31.71% | -16.34% | |||
| Cost of Revenue | -20.32% | -8.15% | |||
| Gross Profit | 370.02% | -47.03% | |||
| SG&A Expenses | 8.88% | -11.97% | |||
| Depreciation & Amortization | 0.02% | -0.47% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.65% | -8.49% | |||
| Operating Income | 50.91% | -18.60% | |||
| Income Before Tax | 78.02% | -29.92% | |||
| Income Tax Expenses | 18.45% | 60.99% | |||
| Earnings from Continuing Operations | 84.66% | -75.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 84.66% | -75.47% | |||
| EBIT | 50.91% | -18.60% | |||
| EBITDA | 90.86% | -39.59% | |||
| EPS Basic | 84.65% | -77.21% | |||
| Normalized Basic EPS | 44.92% | -12.65% | |||
| EPS Diluted | 84.65% | -74.64% | |||
| Normalized Diluted EPS | 44.92% | -12.65% | |||
| Average Basic Shares Outstanding | -0.48% | -0.87% | |||
| Average Diluted Shares Outstanding | -0.48% | -0.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||